Therapeutic Advances in Endocrinology and Metabolism

Papers
(The H4-Index of Therapeutic Advances in Endocrinology and Metabolism is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review178
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity157
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults72
Controversies in the management of active Charcot neuroarthropathy48
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review45
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study36
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis33
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach32
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers27
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses25
Leave no bone unturned: metabolic bone disease in special populations23
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system23
Update on genetics and epigenetics in metabolic associated fatty liver disease23
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study22
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease22
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor21
Pheochromocytoma: a changing perspective and current concepts21
Is there a causal relationship between hypothyroidism and hyponatremia?21
Using digital tools to improve diabetes care in India with continuous glucose monitoring20
Diagnostic performance of morning basal serum cortisol for assessing adrenal reserve: a single-center experience from the United Arab Emirates20
0.18538498878479